Evidence map›Paper›PMID 20161478›Full record

ReviewFuture medicinal chemistry2009

Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments.

I H Bellayr, X Mu, Y Li

Open access · greenAbstract readReview
In one paragraph

Review in Future medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Melatonin signalling in Schwann cells during neuroregeneration.Frontiers in cell and developmental biology · 2022
    Review
  12. Review
  13. Oxidative medicine and cellular longevity · 2021
    Article
  14. Review
  15. Article
  16. Fibrosis following Acute Skeletal Muscle Injury: Mitigation and Reversal Potential in the Clinic.Journal of sports medicine (Hindawi Publishing Corporation) · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

I H BellayrThe Laboratory of Molecular Pathology, Stem Cell Research Center, Children's Hospital of UPMC, and Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15213-2582, USA.
X Mu
Y Li
Children's Hospital of Pittsburgh · US

Funding

Use of matrix metalloproteinase to improve myogenic cell transplantation in MDX mR21AR055725 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, YONG · 2008 to 2009
$347k
NIAMS NIH HHS R21 AR055725
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) are a group of proteases that belong to the metazincin family. These proteins consist of similar structures featuring a signaling peptide, a propeptide domain, a catalytic domain where the notable zinc ion binding site is found and a hinge region that binds to the C-terminal hemoplexin domain. MMPs can be produced by numerous cell types through secretion or localization to the cell membrane. While certain chemical compounds have been known to generally inhibit MMPs, naturally occurring proteins known as tissue inhibitors of metalloproteinases (TIMPs) effectively interact with MMPs to modify their biological roles. MMPs are very important enzymes that actively participate in remodeling the extracellular matrix by degrading certain constituents, along with promoting cell proliferation, migration, differentiation, apoptosis and angiogenesis. In normal adult tissue, they are almost undetectable; however, when perturbed through injury, disease or pregnancy, they have elevated expression. The goal of this review is to identify new experimental findings that have provided further insight into the role of MMPs in skeletal muscle, nerve and dermal tissue, as well as in the liver, heart and kidneys. Increased expression of MMPs can improve the regeneration potential of wounds; however, an imbalance between MMP and TIMP expression can prove to be destructive for afflicted tissues.

Indexed as

AnimalsCentral Nervous SystemEnzyme ActivationFemaleHeartHumansKidneyLiverMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesMuscle, SkeletalPregnancyProtein PrecursorsRegenerationSkinTissue Inhibitor of MetalloproteinasesMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesProtein PrecursorsTissue Inhibitor of Metalloproteinases

Identifiers

PMID20161478
PMCPMC2794138
OpenAlexW2099170891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.